These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24958721)

  • 1. Type II fatty acid synthesis is essential for the replication of Chlamydia trachomatis.
    Yao J; Abdelrahman YM; Robertson RM; Cox JV; Belland RJ; White SW; Rock CO
    J Biol Chem; 2014 Aug; 289(32):22365-76. PubMed ID: 24958721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Targets in Chlamydial Fatty Acid and Phospholipid Synthesis.
    Yao J; Rock CO
    Front Microbiol; 2018; 9():2291. PubMed ID: 30319589
    [No Abstract]   [Full Text] [Related]  

  • 3. Enoyl-Acyl Carrier Protein Reductase I (FabI) Is Essential for the Intracellular Growth of Listeria monocytogenes.
    Yao J; Ericson ME; Frank MW; Rock CO
    Infect Immun; 2016 Dec; 84(12):3597-3607. PubMed ID: 27736774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).
    Yao J; Maxwell JB; Rock CO
    J Biol Chem; 2013 Dec; 288(51):36261-71. PubMed ID: 24189061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Exogenous Fatty Acids to Acyl-Acyl Carrier Protein Cannot Bypass FabI Inhibition in Neisseria.
    Yao J; Bruhn DF; Frank MW; Lee RE; Rock CO
    J Biol Chem; 2016 Jan; 291(1):171-81. PubMed ID: 26567338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ternary complex formation of AFN-1252 with Acinetobacter baumannii FabI and NADH: Crystallographic and biochemical studies.
    Rao NK; Nataraj V; Ravi M; Panchariya L; Palai K; Talapati SR; Lakshminarasimhan A; Ramachandra M; Antony T
    Chem Biol Drug Des; 2020 Aug; 96(2):704-713. PubMed ID: 32227402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia trachomatis Scavenges Host Fatty Acids for Phospholipid Synthesis via an Acyl-Acyl Carrier Protein Synthetase.
    Yao J; Dodson VJ; Frank MW; Rock CO
    J Biol Chem; 2015 Sep; 290(36):22163-73. PubMed ID: 26195634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activity.
    Rao KN; Lakshminarasimhan A; Joseph S; Lekshmi SU; Lau MS; Takhi M; Sreenivas K; Nathan S; Yusof R; Abd Rahman N; Ramachandra M; Antony T; Subramanya H
    Protein Sci; 2015 May; 24(5):832-40. PubMed ID: 25644789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acylated Derivatives of Sulfamethoxazole Block Chlamydia Fatty Acid Synthesis and Interact with FabF.
    Mojica SA; Salin O; Bastidas RJ; Sunduru N; Hedenström M; Andersson CD; Núñez-Otero C; Engström P; Valdivia RH; Elofsson M; Gylfe Å
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitor.
    Kaplan N; Albert M; Awrey D; Bardouniotis E; Berman J; Clarke T; Dorsey M; Hafkin B; Ramnauth J; Romanov V; Schmid MB; Thalakada R; Yethon J; Pauls HW
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5865-74. PubMed ID: 22948878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
    Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
    Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sunflower (Helianthus annuus) fatty acid synthase complex: enoyl-[acyl carrier protein]-reductase genes.
    González-Thuillier I; Venegas-Calerón M; Garcés R; von Wettstein-Knowles P; Martínez-Force E
    Planta; 2015 Jan; 241(1):43-56. PubMed ID: 25204631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand- and Structure-Based Approaches of Escherichia coli FabI Inhibition by Triclosan Derivatives: From Chemical Similarity to Protein Dynamics Influence.
    Kronenberger T; de Oliveira Fernades P; Drumond Franco I; Poso A; Gonçalves Maltarollo V
    ChemMedChem; 2019 Dec; 14(23):1995-2004. PubMed ID: 31670463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-branched fatty acids, inhibitors of enoyl-ACP reductase with antibacterial activity from Streptomyces sp. A251.
    Zheng CJ; Sohn MJ; Chi SW; Kim WG
    J Microbiol Biotechnol; 2010 May; 20(5):875-80. PubMed ID: 20519910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
    Massengo-Tiassé RP; Cronan JE
    J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
    Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
    Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbation of Staphylococcus aureus gene expression by the enoyl-acyl carrier protein reductase inhibitor AFN-1252.
    Parsons JB; Kukula M; Jackson P; Pulse M; Simecka JW; Valtierra D; Weiss WJ; Kaplan N; Rock CO
    Antimicrob Agents Chemother; 2013 May; 57(5):2182-90. PubMed ID: 23459481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials.
    Shima K; Kaufhold I; Eder T; Käding N; Schmidt N; Ogunsulire IM; Deenen R; Köhrer K; Friedrich D; Isay SE; Grebien F; Klinger M; Richer BC; Günther UL; Deepe GS; Rattei T; Rupp J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.